Nivolumab vs Vancomycin
Nivolumab vs Vancomycin: Overview
This comparison examines the pharmacological differences between Nivolumab and Vancomycin.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Vancomycin: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.
Pharmacokinetics
Half-life: Nivolumab β 27 days; Vancomycin β 4-6 hours.
Chemical Properties
Molecular Formula: Vancomycin β C66H75Cl2N9O24.
Molecular Weight: Vancomycin β 1449.2500 g/mol.
Type: Nivolumab β Antibody; Vancomycin β Small molecule.